Literature DB >> 19307383

Can the Ottawa knee rule be applied to children? A systematic review and meta-analysis of observational studies.

D Vijayasankar1, A A Boyle, P Atkinson.   

Abstract

BACKGROUND: The Ottawa knee rule (OKR), a clinical decision aid is used to reduce unnecessary radiography. It is not clear whether this rule can be applied to children.
OBJECTIVE: To establish whether the OKR had adequate sensitivity and acceptable specificity in children to advocate widespread use.
METHODS: A systematic review and meta-analysis was conducted of observational studies that examined the diagnostic characteristics of the OKR in children. DATA SOURCES: Relevant English language articles were identified from Medline (1950 to date), EMBASE (1974 to date), CINAHL (1982 to date), the Cochrane Library, Google Scholar and a hand search of bibliographies. STUDY SELECTION: Observational studies that included children and have used the OKR for ruling out fractures in children either radiologically or in combination with follow-up.
RESULTS: Four relevant studies were identified. Three studies were suitable for inclusion in the meta-analysis, representing 1130 children. The pooled negative likelihood ratio was 0.07 (95% CI 0.02 to 0.29), the pooled positive likelihood ratio was 1.94 (95% CI 1.60 to 2.36), the pooled sensitivity was 99% (CI 94.4 to 99.8) and the pooled specificity was 46% (CI 43.0 to 49.1). The reduction in radiography was between 30% and 40%.
CONCLUSION: The OKR has high sensitivity and adequate specificity for children over the age of 5 years. There are not enough good data to advocate application of the OKR in children less than 5 years.

Entities:  

Mesh:

Year:  2009        PMID: 19307383     DOI: 10.1136/emj.2008.063131

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  1 in total

1.  The Ottawa knee rule: examining use in an academic emergency department.

Authors:  Bryan G Beutel; Samir K Trehan; Robert M Shalvoy; Michael J Mello
Journal:  West J Emerg Med       Date:  2012-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.